Investigating the effect of UC‐MSCT on T cells and FLSs from RA patients showed UC‐MSCs inhibited proliferation, and invasiveness of FLSs by the production of IL‐10, TGF‐β, and reduction of matrix metalloproteinases 9 expression. This evidence concerns the gene IL10 and rheumatoid arthritis.